プログラム

第9回武田科学振興財団薬科学シンポジウム

Wednesday,
February 7
9:30 Opening Remarks
  Session 1
 
Chairperson Toni Cathomen University Medical Center Freiburg, Germany
9:40
・S1-1 CRISPR-Cas Technologies for Targeted Genome and Epigenome Editing
J. Keith Joung : Massachusetts General Hospital / Harvard Medical School, U.S.A.
10:15
・S1-2 Epigenome and genome editing of mammals
Izuho Hatada : Gunma University, Japan
10:50 Coffee Break
  Session 2
 
Chairperson Keith Joung Massachusetts General Hospital, USA
11:10
・S2-1 Expanding the CRISPR-Cas Genome Engineering Toolbox
Feng Zhang : The McGovern Institute, MIT, U.S.A.
11:45
・S2-2 Molecular mechanism of CRISPR and structure-based development of genome editing tools towards gene therapy
Osamu Nureki : The University of Tokyo, Japan
12:20 Speakers' Photo Session
12:30 Lunch & Poster Session
[Poster Session]Odd No. 13:20 - 14:10 Even No. 14:10 - 15:00
  Session 3
 
Chairperson Takashi Yamamoto Hiroshima University, Japan
15:05
・S3-1 Optical control of the genome
Moritoshi Sato : The University of Tokyo
15:40
・S3-2 Structures and molecular mechanisms of CRISPR-Cas genome editor nucleases
Martin Jinek : University of Zurich, Switzerland
16:15 Coffee Break
  Session 4
 
Chairperson Danwei Huangfu Memorial Sloan Kettering Cancer Center, USA
16:35
・S4-1 Chromosomal engineering with CRISPR/Cas9 system in human iPS cells
Junji Takeda : Osaka University, Japan
16:55
・S4-2 Creation and correction of human disease alleles through microhomology-mediated end joining (MMEJ)
Knut Woltjen : Kyoto University, Japan
17:30
・S4-3 Microhomology-mediated end-joining (MMEJ)-assisted genome editing in cultured cells and animals
Takashi Yamamoto : Hiroshima University, Japan
  Publishing with Science
 
Chairperson Osamu Nureki The University of Tokyo, Japan
18:05
・Opening the black box: an editor's perspective on scientfic publishing
Steve Mao : Science Magazine/AAAS, U.S.A.
18:30 Welcome Reception
Thursday,
February 8
  Session 5
 
Chairperson Junji Takeda Osaka University, Japan
9:00
・S5-1 Biallelic genome editing of a reference human stem cell line
William C. Skarnes : The Jackson Laboratory for Genomic Medicine, U.S.A.
9:35
・S5-2 Development and application of CRISPR screening in mammalian cells
Kosuke Yusa : Wellcome Trust Sanger Institute, UK
10:10 Coffee Break
  Session 6
 
Chairperson Kosuke Yusa Wellcome Trust Sanger Institute, UK
10:25
・S6-1 Therapeutic genome editing in human stem cells
Toni Cathomen : University Medical Center Freiburg, Germany
11:00
・S6-2 Human development and disease through the lens of pluripotent stem cells
Danwei Huangfu : Memorial Sloan Kettering Cancer Center, U.S.A.
11:35
・S6-3 Genome Editing Therapy for Duchenne Muscular Dystrophy in iPS Cells and in vivo
Akitsu Hotta : Kyoto University, Japan
12:10 Lunch & Poster Session
[Free Discussion]13:00 - 13:30
  Session 7
 
Chairperson Izuho Hatada Gunma University, Japan
13:30
・S7-1 Genome-editing applied to the generation of genetically engineered rats for biomedical research
Ignacio Anegon : INSERM Center for Research in Transplantation and Immunology, France
14:05
・S7-2 CRISPR-mediated genome engineering in mice, rats, and rabbits
Tomoji Mashimo : Osaka University, Japan
14:40
・S7-3 CRISPR/Cas9 mediated genome editing in mice and its application for the study of reproduction
Masahito Ikawa : Osaka University, Japan
15:15 Coffee Break
  Session 8
 
Chairperson Ignacio Anegon INSERM Center for Research in Transplantation and Immunology, France
15:30
・S8-1 Genome-wide Target Specificities of CRISPR Nucleases and Deaminases
Jin-Soo Kim : Institute for Basic Science / Soul National University, Korea
16:05
・S8-2 Generation of non-human primate disease model by genome editing
Erika Sasaki : Central Institute for Experimental Animals, Japan
16:40
・S8-3 Strategy and Tactics for Genome- Editing Therapy in Hematology
Yutaka Hanazono : Jichi Medical University, Japan
17:15 Award Presentation Ceremony & Closing Remarks